SonoScape Medical Corp. (SHE:300633)

Market Cap	9.03B -30.0%
Revenue (ttm)	2.44B +17.5%
Net Income	175.27M +161.9%
EPS	0.41 +164.3%
Shares Out	422.45M
PE Ratio	52.18
Forward PE	26.89
Dividend	0.18 (0.84%)
Ex-Dividend Date	Jun 5, 2026

Volume	5,021,508
Open	22.31
Previous Close	21.30
Day's Range	21.03 - 22.31
52-Week Range	17.20 - 30.24
Beta	-0.42
Analysts	Buy
Price Target	27.61 (+29.2%)
Earnings Date	Oct 29, 2026

About SonoScape Medical

SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, light sources, gastroenterology and pulmonology products, endoscopic ultrasound, duodenoscopes, and peripheral equipment; minimally invasive surgery soluti...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 3,133
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300633

Financial Performance

In 2025, SonoScape Medical's revenue was 2.31 billion, an increase of 14.65% compared to the previous year's 2.01 billion. Earnings were 197.28 million, an increase of 38.54%.

Analyst Summary

According to 7 analysts, the average rating for 300633 stock is "Buy." The 12-month stock price target is ¥27.61, which is an increase of 29.20% from the latest price.

Price Target

¥27.61

(29.20% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error